ArticleFrontiers in public health2026
Evaluating AI chatbots for providing health advice on occupational sedentary behavior in the workplace.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Office workers accumulate most of their waking h in sedentary behavior, yet scalable personalized occupational-health advice remains limited, and the quality of large language model (LLM)-based tools in this domain has not been rigorously examined. Objective: This study evaluated whether a domain-specialized chatbot system for providing health advice on sedentary behavior, integrating retrieval augmentation, a curated corpus, and safety guardrails, performs better than a general-purpose LLM and static educational materials. Methods: A sequential explanatory mixed-methods design was used. In the blinded expert evaluation, nine raters independently rated 60 responses across five quality dimensions. In the user survey, 654 eligible Chinese office workers interacted with the specialized chatbot and completed six perception scales (two adapted from established technology-acceptance frameworks and four developed for this study) plus open-ended feedback. Results: Inter-rater reliability was good for the composite score; in a case-level safety screen, no response from the specialized chatbot or the standard materials was flagged as potentially unsafe, whereas two Doubao responses were flagged by two or more raters. The specialized chatbot achieved the highest composite rating, followed by Doubao and standard materials. In a linear mixed-effects model and crossed random intercepts for rater and question, all Holm-adjusted pairwise contrasts were significant. Advantages of the specialized chatbot over Doubao were most pronounced on safety in symptom-management and special-population items. Among users, perceived ease of use was highest, whereas perceived safety and intention to use were rated comparatively lower. Frequent prior AI-chatbot use was associated with higher ratings on all six scales; after covariate adjustment the association persisted for five of the six scales but was attenuated and no longer significant for perceived safety. Conclusion: The specialized chatbot system received expert-rated accuracy and safety scores that did not differ significantly from standard educational materials, but exceeded standard materials on usefulness, comprehensibility, and completeness, and outperformed the general-purpose LLM on accuracy, safety, completeness, and the overall composite score. These findings concern response quality and immediate user perceptions, not behavioral or clinical outcomes. Nonetheless, users remained cautious about safety and intention to use after this brief exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.